共有 50 笔近期内部人交易记录记录，涉及 AVROBIO, Inc. (AVRO), 包括 39 笔买入 和 9 笔卖出. 内部人买入总额为 $2.93M 内部人卖出总额为 $303.13K.
近期活跃的重要内部人包括 Leonard Braden Michael, Avruch Steven, Ostrowski Erik. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — AVRO
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-05-14 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
296,882 |
$1.30 |
$385.95K |
4,768,262 |
| 2024-05-13 |
Leonard Braden Michael |
10 Percent Owner |
未知 |
- |
- |
- |
4,471,380 |
| 2024-05-13 |
Leonard Braden Michael |
10 Percent Owner |
知情买入 |
253,700 |
$1.24 |
$313.32K |
4,255,327 |
| 2024-05-13 |
Leonard Braden Michael |
10 Percent Owner |
处置 |
- |
- |
- |
400,000 |
| 2024-02-05 |
Avruch Steven |
Chief Legal Officer |
RSU 预扣税 |
10,812 |
$1.20 |
$13K |
22,022 |
| 2024-02-05 |
Ostrowski Erik |
Interim CEO, President and CFO |
RSU 预扣税 |
13,099 |
$1.20 |
$15.74K |
29,285 |
| 2024-02-05 |
Ridha Essra |
Chief Medical Officer |
RSU 预扣税 |
16,953 |
$1.20 |
$20.35K |
15,881 |
| 2024-02-05 |
Golipour Azadeh |
Chief Technology Officer |
RSU 预扣税 |
12,232 |
$1.20 |
$14.7K |
55,872 |
| 2024-02-01 |
Avruch Steven |
Chief Legal Officer |
期权行权 |
32,834 |
- |
- |
32,834 |
| 2024-02-01 |
Ostrowski Erik |
Interim CEO, President and CFO |
期权行权 |
40,084 |
- |
- |
42,384 |
| 2024-02-01 |
Ridha Essra |
Chief Medical Officer |
期权行权 |
32,834 |
- |
- |
32,834 |
| 2024-02-01 |
Golipour Azadeh |
Chief Technology Officer |
期权行权 |
37,334 |
- |
- |
68,104 |
| 2023-07-01 |
Ostrowski Erik |
Interim CEO, President and CFO |
限制性股票授予 (RSU) |
70,000 |
- |
- |
70,000 |
| 2023-06-12 |
Golipour Azadeh |
Chief Technology Officer |
RSU 预扣税 |
111 |
$1.21 |
$133.76 |
30,770 |
| 2023-06-06 |
Donenberg Phillip B. |
Director |
限制性股票授予 (RSU) |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Clark Ian T |
Director |
限制性股票授予 (RSU) |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Booth Bruce |
Director |
限制性股票授予 (RSU) |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Farfel Gail M |
Director |
限制性股票授予 (RSU) |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Vickers Philip J. |
Director |
限制性股票授予 (RSU) |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Jenkins Annalisa |
Director |
限制性股票授予 (RSU) |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Paige Christopher |
Director |
限制性股票授予 (RSU) |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-02-08 |
Petersen Deanna M |
Chief Business Officer |
限制性股票授予 (RSU) |
86,667 |
- |
- |
86,667 |
| 2023-02-08 |
Mackay Geoffrey |
President & CEO |
限制性股票授予 (RSU) |
300,667 |
- |
- |
300,667 |
| 2023-02-08 |
Avruch Steven |
Chief Legal Officer |
限制性股票授予 (RSU) |
131,333 |
- |
- |
131,333 |
| 2023-02-08 |
Ostrowski Erik |
Chief Financial Officer |
限制性股票授予 (RSU) |
160,333 |
- |
- |
160,333 |
| 2023-02-08 |
Ridha Essra |
Chief Medical Officer |
限制性股票授予 (RSU) |
131,333 |
- |
- |
131,333 |
| 2023-02-08 |
Golipour Azadeh |
Chief Technology Officer |
限制性股票授予 (RSU) |
149,333 |
- |
- |
149,333 |
| 2023-01-24 |
Mackay Geoffrey |
President & CEO |
期权行权（卖出） |
45,999 |
- |
- |
- |
| 2022-12-28 |
Mackay Geoffrey |
President & CEO |
赠与（送出） |
245,123 |
- |
- |
142,013 |
| 2022-12-23 |
Mackay Geoffrey |
President & CEO |
期权行权（卖出） |
142,013 |
- |
- |
- |
| 2022-12-08 |
Petersen Deanna M |
Chief Business Officer |
限制性股票授予 (RSU) |
111,500 |
- |
- |
111,500 |
| 2022-12-08 |
Mackay Geoffrey |
President & CEO |
限制性股票授予 (RSU) |
388,000 |
- |
- |
388,000 |
| 2022-12-08 |
Avruch Steven |
Chief Legal Officer |
限制性股票授予 (RSU) |
169,500 |
- |
- |
169,500 |
| 2022-12-08 |
Ostrowski Erik |
Chief Financial Officer |
限制性股票授予 (RSU) |
221,000 |
- |
- |
221,000 |
| 2022-12-08 |
Ridha Essra |
Chief Medical Officer |
限制性股票授予 (RSU) |
183,000 |
- |
- |
183,000 |
| 2022-12-08 |
Golipour Azadeh |
Chief Technology Officer |
限制性股票授予 (RSU) |
165,000 |
- |
- |
165,000 |
| 2022-06-08 |
Donenberg Phillip B. |
Director |
限制性股票授予 (RSU) |
17,478 |
- |
- |
17,478 |
| 2022-06-08 |
Clark Ian T |
Director |
限制性股票授予 (RSU) |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Booth Bruce |
Director |
限制性股票授予 (RSU) |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Farfel Gail M |
Director |
限制性股票授予 (RSU) |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Vickers Philip J. |
Director |
限制性股票授予 (RSU) |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Jenkins Annalisa |
Director |
限制性股票授予 (RSU) |
17,478 |
- |
- |
17,478 |
| 2022-06-08 |
Paige Christopher |
Director |
限制性股票授予 (RSU) |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Golipour Azadeh |
Chief Technology Officer |
处置 |
130,000 |
$1.84 |
$239.2K |
- |
| 2022-02-02 |
Petersen Deanna M |
Chief Business Officer |
限制性股票授予 (RSU) |
80,000 |
$1.84 |
$147.2K |
80,000 |
| 2022-02-02 |
Mackay Geoffrey |
President & CEO |
限制性股票授予 (RSU) |
328,500 |
$1.84 |
$604.44K |
328,500 |
| 2022-02-02 |
Avruch Steven |
Chief Legal Officer |
限制性股票授予 (RSU) |
90,000 |
$1.84 |
$165.6K |
90,000 |
| 2022-02-02 |
Ostrowski Erik |
Chief Financial Officer |
限制性股票授予 (RSU) |
145,000 |
$1.84 |
$266.8K |
145,000 |
| 2022-02-02 |
Ridha Essra |
Chief Medical Officer |
限制性股票授予 (RSU) |
75,000 |
$1.84 |
$138K |
75,000 |
| 2021-11-01 |
Ridha Essra |
Chief Medical Officer |
限制性股票授予 (RSU) |
120,000 |
$5.67 |
$680.4K |
120,000 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
